Debra Resta

Pharmacodynamics of daily subcutaneous recombinant human interleukin‐3 in normal volunteers

J. Seibold, D. Resta, L. Myers, 1995, Clinical pharmacology and therapeutics.

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

C. Sawyers, H. Kantarjian, J. Ford, 2001, The New England journal of medicine.